We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+0.65%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$73.9B
AUM Growth
-$2.32B
(-3%)
Cap. Flow
-$2.03B
Cap. Flow
% of AUM
-2.75%
Top 10 Holdings %
Top 10 Hldgs %
22.54%
Holding
3,088
New
92
Increased
1,359
Reduced
1,564
Closed
46
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$60.7M |
| 2 |
Analog Devices
ADI
|
+$46.1M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$37.3M |
| 4 |
Match Group
MTCH
|
+$28.2M |
| 5 |
GXO Logistics
GXO
|
+$19.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$89.3M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$78.9M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$77.4M |
| 4 |
Apple
AAPL
|
+$77M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$70.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.91% |
| 2 | Financials | 14.2% |
| 3 | Healthcare | 13.07% |
| 4 | Consumer Discretionary | 12.09% |
| 5 | Communication Services | 9.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Gartner
IT
$11.6B
| $41.1M | 0.06% |
135,261
-531
| -0.4% | -$154K |
|
302
Realty Income
O
$58.5B
| $40.9M | 0.06% |
650,771
+8,765
| +1% | +$592K |
|
303
Workday
WDAY
$41.6B
| $40.7M | 0.06% |
162,997
-9,716
| -6% | -$2.41M |
|
|
GRMN
304
Garmin
GRMN
$58.6B
| $40.6M | 0.06% |
261,435
-68,202
| -21% | -$11.1M |
|
305
Extra Space Storage
EXR
$31.8B
| $40.2M | 0.05% |
239,548
-4,443
| -2% | -$785K |
|
306
Camden Property Trust
CPT
$11B
| $40.2M | 0.05% |
272,852
-2,374
| -0.9% | -$348K |
|
307
Quest Diagnostics
DGX
$26.2B
| $40M | 0.05% |
275,616
-14,819
| -5% | -$2.17M |
|
308
Marvell Technology
MRVL
$191B
| $40M | 0.05% |
663,272
-55,629
| -8% | -$3.33M |
|
309
Factset
FDS
$9.79B
| $39.9M | 0.05% |
101,026
-1,149
| -1% | -$418K |
|
310
Albemarle
ALB
$15B
| $39.9M | 0.05% |
182,029
-1,867
| -1% | -$399K |
|
311
Corning
GLW
$136B
| $39.7M | 0.05% |
1,088,719
-17,642
| -2% | -$704K |
|
312
Nasdaq
NDAQ
$52.8B
| $39.5M | 0.05% |
613,401
+3,987
| +0.7% | +$251K |
|
313
Paycom
PAYC
$9.85B
| $39.4M | 0.05% |
79,383
+121
| +0.2% | +$53.9K |
|
314
Expedia Group
EXPE
$37.1B
| $39.3M | 0.05% |
239,726
+8,009
| +3% | +$1.24M |
|
315
Expeditors International
EXPD
$23.1B
| $39.2M | 0.05% |
328,832
+1,334
| +0.4% | +$167K |
|
316
LyondellBasell Industries
LYB
$20B
| $39.2M | 0.05% |
417,381
+4,367
| +1% | +$429K |
|
|
KSU
317
DELISTED
Kansas City Southern
KSU
| $39.1M | 0.05% |
144,644
-2,464
| -2% | -$686K |
|
318
Repligen
RGEN
$8.96B
| $39.1M | 0.05% |
135,370
-784
| -0.6% | -$201K |
|
319
Hartford Financial Services
HIG
$39.5B
| $38.9M | 0.05% |
553,266
-25,875
| -4% | -$1.71M |
|
320
Devon Energy
DVN
$49.8B
| $38.8M | 0.05% |
1,092,800
-37,007
| -3% | -$1.05M |
|
321
Dover
DOV
$28.4B
| $38.8M | 0.05% |
249,425
-5,846
| -2% | -$968K |
|
322
Broadridge
BR
$18.6B
| $38.8M | 0.05% |
232,688
+28,846
| +14% | +$4.91M |
|
323
Oneok
OKE
$55.3B
| $38.6M | 0.05% |
665,799
-18,258
| -3% | -$981K |
|
324
Clorox
CLX
$12.8B
| $38.4M | 0.05% |
231,761
-3,864
| -2% | -$665K |
|
325
Consolidated Edison
ED
$40B
| $37.9M | 0.05% |
522,536
-15,424
| -3% | -$1.15M |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2021 Portfolio in Review
As of Q3 2021, RhumbLine Advisers held 3,088 positions worth $73.9B, down 3% from $76.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Trading was light in Q3 2021: portfolio turnover was 4.5%. RhumbLine Advisers opened 92 new positions and exited 46, leaving the 3,088-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q3 2021 buy was GXO Logistics: 250,722 shares worth $19.7M.
- RhumbLine Advisers added most to Moderna in Q3 2021, an estimated $60.7M increase.
- RhumbLine Advisers's biggest Q3 2021 reduction was Microsoft, cutting an estimated $89.3M.
- RhumbLine Advisers fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $77.4M.
- RhumbLine Advisers's ten largest holdings make up 23% of its $73.9B portfolio in Q3 2021.
- RhumbLine Advisers opened 92 new positions and closed 46 in Q3 2021.
- RhumbLine Advisers's portfolio value fell 3% quarter-over-quarter to $73.9B.
Based on RhumbLine Advisers's 13F filing for Q3 2021, filed 12 Nov 2021.